CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B (disorder)
|
0.100 |
Biomarker
|
disease |
BEFREE |
Rab18 Collaborates with Rab7 to Modulate Lysosomal and Autophagy Activities in the Nervous System: an Overlapping Mechanism for Warburg Micro Syndrome and Charcot-Marie-Tooth Neuropathy Type 2B.
|
30721447 |
2019 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B (disorder)
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Missense mutations in RAB7A, the gene encoding the small GTPase Rab7, cause CMT2B and increase Rab7 activity.
|
24521780 |
2014 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B (disorder)
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Four missense mutations in the late endosomal Rab7 GTPase (L129F, K157N, N161T, and V162M) cause the autosomal dominant peripheral neuropathy Charcot-Marie-Tooth type 2B (CMT2B) disease.
|
23188822 |
2013 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B (disorder)
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We propose that Rab7 mutants induce premature degradation of retrograde NGF-TrkA trophic signaling, which may potentially contribute to the CMT2B disease.
|
23616551 |
2013 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B (disorder)
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Four missense mutations of Rab7, a small GTPase of the Rab family involved in intracellular vesicular trafficking, are associated with the CMT2B phenotype.
|
20645406 |
2010 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B (disorder)
|
0.100 |
Biomarker
|
disease |
BEFREE |
Rab7 and the CMT2B disease.
|
19754445 |
2009 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B (disorder)
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
RAB7 mutations were only found in patients with a Charcot-Marie-Tooth type 2B (CMT2B) phenotype, an axonal sensory-motor neuropathy with pronounced ulcero-mutilations.
|
19651702 |
2009 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B (disorder)
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Altogether, these data demonstrate that all tested CMT2B-associated Rab7 mutations are mechanistically similar, suggesting that activated forms of the Rab7 are responsible for CMT2B disease.
|
18272684 |
2008 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B (disorder)
|
0.100 |
Biomarker
|
disease |
BEFREE |
Therefore, activated forms of Rab7 protein cause the CMT2B disease.
|
18501189 |
2008 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B (disorder)
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
This observation strongly supports the hypothesis that RAB7 mutations are responsible for CMT2B.
|
17060578 |
2006 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B (disorder)
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
HSN I is associated with mutations in the SPTLC1 gene, whereas mutations in the RAB7 gene have been identified in CMT 2b.
|
15319794 |
2004 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B (disorder)
|
0.100 |
Biomarker
|
disease |
BEFREE |
There are two known autosomal dominant genes for the hereditary ulcero-mutilating neuropathies: SPTLC1 (hereditary sensory neuropathy type 1) and RAB7 (Charcot-Marie-Tooth disease type 2B).
|
15455439 |
2004 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B (disorder)
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We refined the CMT2B locus to a 2.5-cM region and report two missense mutations (Leu129Phe and Val162Met) in the small GTP-ase late endosomal protein RAB7 which causes the CMT2B phenotype in three extended families and in three patients with a positive family history.
|
12545426 |
2003 |